News Release  

Innovative BayCuff™ Program Empowers Young Members of
Hemophilia A Community to Take Control of Their Treatment

WAYNE, NJ, July 9, 2009 – Today, Bayer HealthCare Pharmaceuticals launched the BayCuff™ self-infusion training program, an educational initiative designed to make infusion of recombinant factor VIII easier for both patients with hemophilia A and for their caregivers.  The centerpiece of the program is an adjustable cuff worn on the hand or arm that allows patients to practice the technique of self-injection without actually infusing themselves and helps caregivers learn to administer home infusions for others. BayCuff press release FINAL

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.